The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries that suppress drug prices.

President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S.